NCT06505668View on ClinicalTrials.gov

Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Treatment Resistant SchizophreniaClozapine Adverse ReactionHeart Rate VariabilityTachycardia
Interventions
DRUG

Atenolol 25 mg

Patients will be receiving Atenolol 25mg OD for 2 months.

DRUG

Ivabradine 10mg

Patients will be receiving Ivabradine 5mg BD for 2 months.

Trial Locations (1)

751019

RECRUITING

All India Institute of Medical Sciences, Bhubaneswar

All Listed Sponsors
lead

All India Institute of Medical Sciences, Bhubaneswar

OTHER